$ENGN SEC Filings

Filed On	Filing
24 Sep 2026	Form 4: Grossman William, Director Bought 5,102 shares ($10.1K)
08 Sep 2026	8-K: Results of Operations and Financial Condition Data update on key regulatory endpoints, complete response (CR) at any time and maturing durability, as well as landmark CR rates from LEGEND's pivotal cohort planned for 4Q 2026
08 Sep 2026	10-Q
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	SCHEDULE 13G/A
11 Aug 2026	8-K: Other Events
22 Jul 2026	Form 3: Chinoporos Constantine, Interim Chief Business Officer
22 Jul 2026	Form 3: Richton Kathleen P., SVP, Finance and Treasurer Holds 6,900 shares of Common Shares
22 Jul 2026	SCHEDULE 13G
17 Jul 2026	8-K: Regulation FD Disclosure
16 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
18 Jun 2026	8-K/A: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation As previously disclosed in the Company’s Original Form 8-K, effective June 14, 2026, the Company’s board of directors (the “Board”) approved a plan to reduce the Company’s workforce by approximately 50% to streamline operations and prese...
17 Jun 2026	Form 4: Astley-Sparke Philip, Director Granted 31,000 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Brunk Gerald A, Director Granted 31,000 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Glickman Richard M, Director Granted 31,000 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Grossman William, Director Granted 231,000 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Hastings Paul J, Director Granted 31,000 Stock Option (Right to Buy)

Comments